Emphasis on Research and Development Activities
First written in FY2016. 29 of 30 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2021: 1 of 6 companies on the "Worse" side.
1 other company's latest entry also says "Restated".
- FY2026RestatedAnnual report
「Research and development is conducted by the R&D Department, the Ube Plant Development Group and the ST Development Group. 21 people, approximately 8% of all employees, are engaged in these activities, which cover a broad range of themes without being limited to existing businesses, drawing on the technology and accumulated knowledge developed through the research, manufacture and sale of titanium dioxide and iron oxide.」
The company continues to emphasize research and development and disclosed an R&D organization of 21 people, approximately 8% of all employees. - FY2026-H1RestatedAnnual report
「R&D expenses for the interim consolidated accounting period were ¥120 million. There were no material changes in the status of the group's research and development activities during the interim consolidated accounting period.」
The company stated that there were no material changes in the status of its research and development activities and recorded R&D expenses of ¥120 million. - FY2025-H1RestatedAnnual report
「R&D expenses for the interim consolidated accounting period amounted to ¥119 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated accounting period.」
The company stated that there were no material changes in its policy of emphasizing research and development and recorded R&D expenses of ¥119 million. - FY2024-Q3RestatedAnnual report
「R&D expenses for the nine-month cumulative period of the third quarter of the current consolidated fiscal year amounted to ¥182 million. There were no material changes in the status of the Group's R&D activities during the nine-month cumulative period of the third quarter of the current consolidated fiscal year.」
The company stated that there were no material changes in its policy of emphasizing research and development. - FY2024-Q2RestatedAnnual report
「There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
The company stated that there were no material changes in its policy of emphasizing research and development. - FY2024-Q1RestatedAnnual report
「R&D expenses for the three-month cumulative period of the first quarter of the current consolidated fiscal year amounted to ¥58 million. There were no material changes in the status of the Group's R&D activities during the three-month cumulative period of the first quarter of the current consolidated fiscal year.」
The company stated that there were no material changes in its policy of emphasizing research and development. - FY2023-Q2RestatedAnnual report
「R&D expenses for the six-month cumulative period of the second quarter of the current consolidated fiscal year amounted to ¥129 million. There were no material changes in the status of the Group's R&D activities during the six-month cumulative period of the second quarter of the current consolidated fiscal year.」
The company continues to state that there have been no material changes in its policy of emphasizing research and development. - FY2023-Q1RestatedAnnual report
「R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥63 million. There were no material changes in the status of the group's research and development activities during the cumulative first quarter of the consolidated fiscal year.」
The company continues to state that there were no material changes in its research and development activities, and R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥63 million. - FY2022RestatedAnnual report
「Research and development is conducted by the R&D Department. 18 people, approximately 5% of all employees, are engaged in these activities, which cover a broad range of themes without being limited to existing businesses, drawing on the technology and accumulated knowledge developed through the research, manufacture and sale of the company's principal products, titanium dioxide and iron oxide.」
The company continues to emphasize research and development, and disclosed an R&D organization comprising 18 people, approximately 5% of all employees. - FY2022-Q3RestatedAnnual report
「R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥218 million. There were no material changes in the status of the group's research and development activities during the cumulative third quarter of the consolidated fiscal year.」
The company continues to state that there were no material changes in its research and development activities and recorded R&D expenses of ¥218 million. - FY2022-Q2RestatedAnnual report
「R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥143 million. There were no material changes in the status of the group's research and development activities during the cumulative second quarter of the consolidated fiscal year.」
The company continues to state that there were no material changes in its research and development activities and recorded R&D expenses of ¥143 million. - FY2021-Q3RestatedAnnual report
「R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥235 million. There were no material changes in the status of the group's research and development activities during the cumulative third quarter of the consolidated fiscal year.」
The company continues to state that there were no material changes in the status of its research and development activities, and R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥235 million. - FY2021-Q1RestatedAnnual report
「R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥76 million. There were no material changes in the status of the group's research and development activities during the cumulative first quarter of the consolidated fiscal year.」
The company continues to state that there were no material changes in the status of its research and development activities, and R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥76 million. - FY2020RestatedAnnual report
「Since its founding, our group has placed emphasis on research and development and has devoted considerable effort to these activities.」
The company continues to emphasize research and development, and disclosed 19 employees engaged in R&D and R&D expenses of ¥314 million. - FY2020-Q3RestatedAnnual report
「R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥239 million. There were no material changes in the status of the group's research and development activities during the cumulative third quarter of the consolidated fiscal year.」
The company stated that there were no material changes in its policy of emphasizing research and development and reported R&D expenses of ¥239 million. - FY2020-Q2RestatedAnnual report
「R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥163 million. There were no material changes in the status of the group's research and development activities during the cumulative second quarter of the consolidated fiscal year.」
The company stated that there were no material changes in its research and development activities and reported R&D expenses of ¥163 million for the cumulative second quarter of the consolidated fiscal year. - FY2020-Q1RestatedAnnual report
「R&D expenses for the cumulative first quarter were ¥79 million. There were no material changes in the status of the company's research and development activities during the cumulative first quarter.」
The company stated that there were no material changes in its policy of emphasizing research and development and reported first-quarter R&D expenses of ¥79 million. - FY2019RestatedAnnual report
「Since its founding, the company has placed emphasis on research and development and has devoted considerable effort to these activities.」
The company continues to emphasize research and development, and stated that R&D expenses for the fiscal year were ¥306 million. - FY2019-Q3RestatedAnnual report
「R&D expenses for the cumulative third quarter were ¥218 million. There were no material changes in the status of the company's research and development activities during the cumulative third quarter.」
The company stated that there were no material changes in its research and development activities and reported R&D expenses of ¥218 million for the cumulative third quarter. - FY2019-Q2RestatedAnnual report
「R&D expenses for the cumulative second quarter were ¥137 million. There were no material changes in the status of the company's research and development activities during the cumulative second quarter.」
The company stated that there were no material changes in its research and development activities and reported first-half R&D expenses of ¥137 million. - FY2019-Q1RestatedAnnual report
「R&D expenses for the cumulative first quarter were ¥68 million. There were no material changes in the status of the company's research and development activities during the cumulative first quarter.」
The company stated that there were no material changes in its research and development activities and reported R&D expenses of ¥68 million for the cumulative first quarter. - FY2018RestatedAnnual report
「Since its founding, the company has placed emphasis on research and development and has devoted considerable effort to these activities.」
The company continues to emphasize research and development, and disclosed 51 employees engaged in R&D and R&D expenses of ¥311 million. - FY2018-Q3RestatedAnnual report
「R&D expenses for the cumulative third quarter were ¥236 million. There were no material changes in the status of the company's research and development activities during the cumulative third quarter.」
The company stated that there were no material changes in its research and development activities and reported R&D expenses of ¥236 million. - FY2018-Q2RestatedAnnual report
「R&D expenses for the cumulative second quarter were ¥161 million. There were no material changes in the status of the company's research and development activities during the cumulative second quarter.」
The company stated that there were no material changes in its research and development activities and reported R&D expenses of ¥161 million for the cumulative second quarter. - FY2018-Q1RestatedAnnual report
「R&D expenses for the cumulative first quarter were ¥80 million. There were no material changes in the status of the company's research and development activities during the cumulative first quarter.」
The company stated that there were no material changes in its research and development activities and reported R&D expenses of ¥80 million for the quarter. - FY2017RestatedAnnual report
「Since its founding, the company has placed emphasis on research and development and has devoted considerable effort to these activities.」
The company continues to emphasize research and development, and disclosed 53 employees engaged in R&D and R&D expenses of ¥281 million. - FY2017-Q3RestatedAnnual report
「R&D expenses for the cumulative third quarter were ¥219 million. There were no material changes in the status of the company's research and development activities during the cumulative third quarter.」
The company explicitly stated that there were no material changes in its research and development activities. R&D expenses were ¥219 million. - FY2017-Q2RestatedAnnual report
「There were no material changes in the status of our research and development activities during the cumulative second quarter.」
The Group explicitly states that there were no significant changes in its research and development activities. - FY2017-Q1RestatedAnnual report
「There were no material changes in the status of the Company’s R&D activities during the cumulative first-quarter period.」
The company explicitly states that there have been no material changes in its R&D activities. - FY2016First statedAnnual report
「Since its founding, the company has placed emphasis on research and development and has devoted considerable effort to these activities.」
The company stated that 52 people, approximately 21% of all employees, are engaged in research and development, and that R&D expenses for the fiscal year were ¥235 million.